Revolutionizing Precision Medicine with the Power of AI and Metabolites
Metabolites are small molecules like glucose & cholesterol that are produced during metabolic processes.
Our patented technology can characterize 20x more metabolites than any other platform for each patient.
We then use these large-scale metabolomic data to create digital metabolic twins, computer representations of metabolic processes within multi-omic contexts.
Metabolic health is currently assessed using oversimplified metrics like BMI, fasting glucose, or limited lipid panels.
We use AI and 10,000+ lipids and metabolites to develop digital metabolic twins.
Our digital metabolic twins predict metabolic health beyond BMI and risk of T2D, CVD, and other chronic diseases.
By utilizing multi-modal metabolomics data, we identify novel biological insights to discover new targets, prioritize them in development, explore indication expansion, and strategize drug combinations.
We enhance clinical trial design by developing fine-tuned AI models based on proprietary pre-trained foundation models. These models increase the likelihood of success and decrease the size of clinical trials.
Our metabolomics data and pre-trained foundation models improve patient genetic stratification. We partner with liquid biopsy companies to increase the accuracy of their ctDNA tests by integrating metabolomics data.
ADDRESS:
ReviveMed Inc
245 First St.,
Cambridge, MA, 02142
Follow us on: